Sequential Paclitaxel and Oxaliplatin HIPEC Followed by XELOX plus Sintilimab in HER2-Negative Peritoneal Metastatic Gastric Cancer (S-HIPEC): A Multicenter, Open-Label, Randomized Trial

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 657e1812d58900b2aa23cde425da26fa69a97dec
First added on: Mar 01, 2025